SC
SLN

Steven Cohen’s Silence Therapeutics SLN Stock Holding History

Steven Cohen’s Portfolio SLN Stock Details SLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-119,711
Closed -$631K – 4529
2026
Q1 		$631K Buy
119,711
+5,641
+5% +$31.1K ﹤0.01% 3021
2025
Q4 		$694K Buy
+114,070
New +$730K ﹤0.01% 3066
2025
Q2 		– Sell
-16,032
Closed -$45.2K – 2578
2025
Q1 		$45.2K Sell
16,032
-617,068
-97% -$3.01M ﹤0.01% 1957
2024
Q4 		$4.36M Buy
633,100
+165,300
+35% +$2.13M 0.01% 997
2024
Q3 		$8.5M Buy
467,800
+321,300
+219% +$5.98M 0.02% 701
2024
Q2 		$2.78M Buy
146,500
+138,300
+1,687% +$2.94M 0.01% 1002
2024
Q1 		$177K Buy
+8,200
New +$178K ﹤0.01% 1921
2023
Q3 		– Sell
-86,700
Closed -$477K – 2838
2023
Q2 		$477K Sell
86,700
-262,762
-75% -$1.58M ﹤0.01% 1275
2023
Q1 		$2.17M Sell
349,462
-21,100
-6% -$249K 0.01% 963
2022
Q4 		$5.65M Sell
370,562
-180,313
-33% -$2.36M 0.02% 719
2022
Q3 		$5.53M Buy
550,875
+300,875
+120% +$3.17M 0.02% 689
2022
Q2 		$2.96M Hold
250,000
– – 0.01% 844
2022
Q1 		$4.75M Hold
250,000
– – 0.02% 719
2021
Q4 		$5.97M Buy
+250,000
New +$5.79M 0.02% 632

Other funds holding SLN

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Steven Cohen's SLN Position: Q2 2026 in Review

Steven Cohen sold out of Silence Therapeutics (SLN) in Q2 2026, closing a stake of 119,711 shares — an estimated $631K sold.

Steven Cohen first reported a position in SLN in Q4 2021 and held it in 14 quarters. The position peaked at $8.5M in Q3 2024. 72 funds tracked by Wall St. Rank hold SLN as of Q2 2026.

  • Steven Cohen reported no remaining Silence Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 119,711 Silence Therapeutics shares in Q2 2026, an estimated $631K.
  • Steven Cohen first reported a position in Silence Therapeutics in Q4 2021 and held it in 14 quarters.
  • Steven Cohen's Silence Therapeutics position peaked at $8.5M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Silence Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.